Effects of ace inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia

Terapevticheskii Arkhiv

Volumn 77, Issue 4, 2005, Pages 55-58

  Vershinina, A M ^a   Gapon, L I ^a   Veber, E E ^a   Popova, S N ^a   Plyusnin, A V ^a  

^a NONE

Author keywords

24 h monitoring of blood pressure; Arterial hypertension; Fosinopril; Hypercholesterolemia; Metoprolol; Obesity; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; METOPROLOL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG ADMINISTRATION; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; HEART INDEX; HEART LEFT VENTRICLE MASS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT SELECTION; PULSE PRESSURE; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOSINOPRIL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; OBESITY;

EID: 20144364999     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wagstaff A. J., Davis R., McTavish M. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension. Drugs 1996; 51: 777-791.
2. ÊïâáçáâáJK. fl., KomoecKoa K). B., Mopbuieea O. H. H Ap. Öè3ÇÇè ñÌ npH JIeHeHHH 3CCCHUHaJIbHOA THnCpTOHMieCKOH SojiesHH c MeTaöojiHHCCKHM cHHjipoMOM. Tep. apx. 1997; 8: 10-12.